Please ensure Javascript is enabled for purposes of website accessibility
ORIGINAL PAPER
Procalcitonin is an effective tool for the diagnosis of generalized forms of infectious complications in patients with acute necrotizing pancreatitis
 
More details
Hide details
1
Department of General Surgery, Bukovinian State Medical University, Chernivtsi, Ukraine
 
2
Department of Pancreas and Biliary Duct Surgery, O.O. Shalimov National Institute of Surgery and Transplantology, Kyiv, Ukraine
 
3
Department of Physical Culture and Basics of Health Studies, Y. Fedkovich National Chernivtsi University, Chernivtsi, Ukraine
 
 
Submission date: 2021-11-02
 
 
Final revision date: 2022-01-05
 
 
Acceptance date: 2022-03-02
 
 
Publication date: 2022-03-31
 
 
Medical Studies 2022;38(1):1-5
 
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Purulent complications worsen the prognosis in patients with acute necrotizing pancreatitis (ANP). Recently procalcitonin (PCT) was proposed as a diagnostic criterion of bacterial contamination of pancreatic necrotic tissue.

Aim of the research:
To evaluate the efficacy of PCT for the early diagnosis of infectious complications of ANP.

Material and methods:
We performed a prospective cohort study of 151 patients with ANP. Before interventional treatment, plasma samples were collected for PCT determination. According to microbiological assay, they were categorized into 4 groups: SIRS without infection, local infection, and sepsis and septic shock. The utility of PCT for diagnosis of infectious complications of ANP was determined by ROC-analysis.

Results:
Infected ANP was diagnosed in 89 (55.6%) patients. Local purulent complications were established at 27 cases, sepsis in 33, and septic shock in 29 patients. In 62 patients with sterile ANP the PCT concentration was higher than in healthy individuals and reached 1.34 ±0.19 ng/ml (p = 0.045). The development of infected ANP was accompanied by an increase of PCT concentration in patients with sepsis to 5.03 ±1.38 ng/ml (p = 0.001) and septic shock – up to 7.21 ±1.91 ng/ml (p = 0.001), while in persons with localized form it was 2.03 ±0.48 ng/ml (p = 0.072). Procalcitonin level above 4.0 ng/ml was prognostically unfavourable for the survival of patients.

Conclusions:
Serum PCT level is an effective tool for the diagnosis of generalized infectious complications of ANP. Its level over 4.0 ng/ml indicates an unfavourable prognosis for patients’ survival.
REFERENCES (14)
1.
Roch A, Maatman T, Carr R. Evolving treatment of necrotizing pancreatitis. Am J Surg 2018; 215: 526-529.
 
2.
Usenko OY, Kopchak VM, Khomiak IV, Khomiak AI, Malik AV. Results of surgical treatment of paraduodenal (groove) pancreatitis. Klinicheskaia Khirurgiia 2019; 85: 5-8.
 
3.
Dronov OI, Nastashenko IL, Susak YM, Tsymbalyuk RS, Tyulyukin IO. Surgical treatment of patients, suffer in an acute biliary pancreatitis and biliary hypertension. Klinicheskaia Khirurgiia 2018; 85: 5-8.
 
4.
Thomson JE, Van Dijk SM, Brand M, Van Santvoort HC, Besselink MG. Managing infected pancreatic necrosis. Chirurgia (Bucur) 2018; 113: 291-299.
 
5.
Yang CJ, Chen J, Phillips AR, Windsor JA, Petrov MS. Predictors of severe and critical acute pancreatitis: a systematic review. Dig Liver Dis 2014; 46: 446-451.
 
6.
Gluszek S, Matykiewicz J, Grabowska U, Chrapek M, Nawacki L, Wawrzycka I, Głuszek-osuch M, Kozieł D. Clinical usefulness of pentraxin 3 (PTX3) as a biomarker of acute pancreatitis and pancreatic cancer. Medical Studies 2020; 36: 6-13.
 
7.
Banks PA, Bollen TL, Dervenis C, Gooszen HG, Johnson CD, Sarr MG, Tsiotos GG, Vege SS. Classification of acute pancreatitis 2012: revision of the Atlanta classification and definitions by international consensus. Gut 2013; 62: 102-111.
 
8.
Sloss A, Kubler P. Prescribing in liver disease. Aust Prescr 2009; 32: 32-35.
 
9.
Rotar O, Khomiak I, Rotar V, Khomiak A, Shafraniuk V, Poliansky O. Determination of grade of gastrointestinal injury and its prognostic utility in patients with acute necrotizing pancreatitis. Med Surg J Revista Med Chir 2018; 122: 759-765.
 
10.
Singer M, Deutschman CS, Seymour CW, Shankar- Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). JAMA 2016; 315: 801-810.
 
11.
Sridharan P, Chamberlain RS. The efficacy of procalcitonin as a biomarker in the management of sepsis: slaying dragons or tilting at windmills? Surgical Infection 2013; 14: 489-511.
 
12.
Covington EW, Roberts MZ, Dong J. Procalcitonin monitoring as a guide for antimicrobial therapy: a review of current literature. Pharmacotherapy 2018; 38: 569-581.
 
13.
Vijayan AL, Vanimaya, Ravindran S. Procalcitonin: a promising diagnostic marker for sepsis and antibiotic therapy. J Intensive Care 2017; 5: 51.
 
14.
Holub M, Džupová O, Růžková M. Selected biomarkers correlate with the origin and severity of sepsis. Mediators Inflammation 2018; 2018: 7028267.
 
eISSN:2300-6722
ISSN:1899-1874
Journals System - logo
Scroll to top